NEW YORK, March 5 - Genome Therapeutics and EraGen Biosciences of Alachua, Fla., will collaborate to combine and co-market EraGen's MasterCatalog bioinformatics platform with Genome Therapeutics' Pathogenome database of microbial genomic sequences, the companies said Monday.
The PathoGenome database offers functionally annotated sequence information on over 30 microbial pathogens, including Staphylococcus , Pseudomonas , Streptococcus , Enterococcus , Acinetobacter , Aspergillus , Bacteroides , Enterobacter , Klebsiella , and Candida species.
MasterCatalog combines data mining and analysis tools with a sequence library of 50,000 protein families and protein families. The companies will fold the Pathogenome sequence information into the MasterCatalog database.
"Combining the Pathogenome database with MasterCatalog's bioinformatics platform increases the discovery potential for both products," said Gary Alianell, COO of EraGen, in a statement. "MasterCatalog's pre-computed protein analyses will streamline the datamining process, allowing biologists to work directly with Pathogenome's data without the aid of a bioinformatics expert."
GenomeTherapeutics offers Pathogenome on a pay-per-use basis through Compugen's search engine LabOnWeb.com. The fee is based on the amount of information accessed per search.
The database is also available by subscription, and its subscribers so far include Aventis, Bayer, bioMerieux, Bristol-Myers Squibb, and Schering-Plough.